KMID : 1001020220200010052
|
|
Journal of Urologic Oncology 2022 Volume.20 No. 1 p.52 ~ p.58
|
|
Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer
|
|
Ku Ja-Yoon
Hwang Eu-Chang Lee Chan-Ho Kim Kyung-Hwan Kwon Dong-Deuk Ha Hong-Koo
|
|
Abstract
|
|
|
Purpose: The aims of this study were to investigate the clinical value of Rab27a as a urinary biomarker, and its efficiency in the prediction of bladder cancer grade.
Materials and Methods: The expression of Rab27a in urine samples of patients with bladder cancer, cell line (T-24), and tissue samples of patients with bladder cancer was estimated via quantitative reverse transcription polymerase chain reaction (qRT-PCR). The Rab27a expression level was investigated according to sex, age, and histological grade via qRT-PCR and Western blotting.
Results: Rab27a was also expressed at high levels in urine compared to cell lines and tissues from bladder cancer patients. In addition, Rab27a expression varied significantly according to tumor grade (p<0.001). Rab27a was expressed at high levels in male and elderly patients, however, there was not statistically significant.
Conclusions: Our results indicated that Rab27a is valuable as a urinary diagnostic biomarker for bladder cancer. In addition, it may serve as a predictive factor for determining bladder cancer grade.
|
|
KEYWORD
|
|
Biomarker, Liquid biopsy, Rab27a, Urinary bladder neoplasms, Urine
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|